Skip to main content
Subcirrhotic liver stiffness in hepatitis B reduces cancer risk

Patients with chronic hepatitis B who achieved a subcirrhotic range of liver stiffness through antiviral therapy had a lower risk of hepatocellular carcinoma, according to a study in the Journal of Gastroenterology and Hepatology. Cancer risks were higher for patients in the cirrhotic range of liver stiffness value after two years of antiviral therapy, compared with those in the subcirrhotic range.

Full Story: